India Begins Subjecting Liquid Medicines To Retail Price Caps
This article was originally published in PharmAsia News
Executive Summary
All liquid medicines in India, including antibiotics and multivitamins, are to be subjected to price caps for the first time by the National Pharmaceutical Pricing Authority. Medicines in liquid form account for 15 percent of the retail market in India, and producers include all domestic drug makers. The drug-pricing authority has notified makers of the maximum retail prices set for 16 medicines that use any of 74 bulk drugs subject to price controls. The NPPA is preventing companies from avoiding the caps by covering all possible pack sizes up to 500ml. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.